Expertise in
18
conditions

Dr. Mark S. Nestor

Dermatology
Office
2925 Aventura Blvd Ste 205, 
Miami, FL 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
18
conditions
Office
2925 Aventura Blvd Ste 205, 
Miami, FL 

Overview

Mark Nestor is a Dermatologist practicing medicine in Miami, Florida.

Dr. Nestor is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Keloids, Actinic Keratosis, Sunburn, Squamous Cell Skin Carcinoma, and Hormone Replacement Therapy (HRT).

He is actively involved in clinical research, co-authoring 94 peer reviewed articles and participating in 10 clinical trials. Dr. Nestor is currently accepting new patients.

Specialties

Dermatology

Licenses

Dermatology in FL

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 20 Less Insurance Carriers -

Locations

Office
2925 Aventura Blvd Ste 205, Miami, FL 33180

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

An Open-Label Dose Escalation Trial to Evaluate Dose Limiting Toxicity (DLT), Maximum Tolerated Dose (MTD), Safety, and Tolerability of Microneedle Arrays Containing Doxorubicin (D-MNA) in Participants With Basal Cell Carcinoma (BCC)
An Open-Label Dose Escalation Trial to Evaluate Dose Limiting Toxicity (DLT), Maximum Tolerated Dose (MTD), Safety, and Tolerability of Microneedle Arrays Containing Doxorubicin (D-MNA) in Participants With Basal Cell Carcinoma (BCC)
Enrollment Status: Terminated
Publish Date: April 16, 2026
Intervention Type: Drug
Study Drug: Microneedle arrays containing doxorubicin
Study Phase: Phase 1
A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions
A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions
Enrollment Status: Active_not_recruiting
Publish Date: May 13, 2025
Intervention Type: Biological, Other
Study Drug: KB301
Study Phase: Phase 1
A Phase 2, Multi-Center, Randomized, Multiple Arm, Controlled Pilot Study to Evaluate the Safety and Efficacy of Various Doses of STP705 in Reducing Post- Keloidectomy Keloid Recurrence
A Phase 2, Multi-Center, Randomized, Multiple Arm, Controlled Pilot Study to Evaluate the Safety and Efficacy of Various Doses of STP705 in Reducing Post- Keloidectomy Keloid Recurrence
Enrollment Status: Completed
Publish Date: March 19, 2024
Intervention Type: Drug, Other
Study Drug: STP705
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intralesional Injection of STP705 in Adult Patients With Cutaneous Squamous Cell Carcinoma in Situ (isSCC)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intralesional Injection of STP705 in Adult Patients With Cutaneous Squamous Cell Carcinoma in Situ (isSCC)
Enrollment Status: Completed
Publish Date: March 18, 2024
Intervention Type: Drug, Other
Study Drug: STP705
Study Phase: Phase 2
A Phase 1 Study to Evaluate the Safety and Tolerability of Subcutaneous Injection of STP705 in Adult Subjects Undergoing Abdominoplasty
A Phase 1 Study to Evaluate the Safety and Tolerability of Subcutaneous Injection of STP705 in Adult Subjects Undergoing Abdominoplasty
Enrollment Status: Completed
Publish Date: March 18, 2024
Intervention Type: Drug
Study Phase: Phase 1
An Open Label, Dose Escalation Study to Evaluate the Safety and Efficacy of Localized Injection of STP705 in Adult Patients With Basal Cell Carcinoma
An Open Label, Dose Escalation Study to Evaluate the Safety and Efficacy of Localized Injection of STP705 in Adult Patients With Basal Cell Carcinoma
Enrollment Status: Completed
Publish Date: March 18, 2024
Intervention Type: Drug
Study Drug: STP705 TGF-Beta1 Cox2 mRNA siRNA Oligonucleotides
Study Phase: Phase 2
A Double-Blind, Pilot Study to Evaluate the Efficacy and Safety of Topical AFX 5931 in the Treatment of Mild to Moderate Hand Dermatitis
A Double-Blind, Pilot Study to Evaluate the Efficacy and Safety of Topical AFX 5931 in the Treatment of Mild to Moderate Hand Dermatitis
Enrollment Status: Completed
Publish Date: January 04, 2023
Intervention Type: Drug
Study Phase: Phase 4
An Open Label, Dose Escalation Study to Evaluate the Safety and Efficacy of Intralesional Injection of STP705 in Adult Patients With Cutaneous Squamous Cell Carcinoma in Situ (isSCC)
An Open Label, Dose Escalation Study to Evaluate the Safety and Efficacy of Intralesional Injection of STP705 in Adult Patients With Cutaneous Squamous Cell Carcinoma in Situ (isSCC)
Enrollment Status: Completed
Publish Date: June 09, 2022
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Prospective, Randomized, Double-blind, Placebo Controlled and Comparative Clinical Study Evaluating Scar-management Modalities for Simple and Effective Management of Hyperproliferative (Hypertrophic) Scars and Keloids
A Prospective, Randomized, Double-blind, Placebo Controlled and Comparative Clinical Study Evaluating Scar-management Modalities for Simple and Effective Management of Hyperproliferative (Hypertrophic) Scars and Keloids
Enrollment Status: Completed
Publish Date: March 21, 2022
Intervention Type: Other
Study Phase: Not Applicable
Randomized, Double-blind, Comparative Pilot Study Investigating the Safety and Clinical Efficacy of Applying a Restorative Wound Care Cream Together With Petrolatum on Anatomically Similar Surgical Excisions
Randomized, Double-blind, Comparative Pilot Study Investigating the Safety and Clinical Efficacy of Applying a Restorative Wound Care Cream Together With Petrolatum on Anatomically Similar Surgical Excisions
Enrollment Status: Completed
Publish Date: March 21, 2022
Intervention Type: Other
Study Phase: Not Applicable
View 9 Less Clinical Trials

94 Total Publications

Non-Light-Based Energy Devices in Aesthetics: Current Evidence and Emerging Innovations.
Non-Light-Based Energy Devices in Aesthetics: Current Evidence and Emerging Innovations.
Journal: The Journal of craniofacial surgery
Published: May 20, 2026
Similar Doctors
Expertise in
31
conditions
Expertise in
31
conditions
Referral required
Before you request
1045 5th Street, 
Miami Beach, FL 
 (12.5 miles away)
305-243-6704
Languages Spoken:
English, Italian
See accepted insurances
Accepting New Patients
Offers Telehealth

Antonella Tosti is a Dermatologist practicing medicine in Miami Beach, Florida. Dr. Tosti is highly rated in 31 conditions, according to our data. Her clinical expertise encompasses Autosomal Recessive Hypotrichosis, Alopecia Areata, Splinter Hemorrhages, and Ringworm. Dr. Tosti is currently accepting new patients.

Expertise in
21
conditions
Expertise in
21
conditions
Referral may be required
5555 Ponce De Leon Boulevard, Floor 3, 
Coral Gables, FL 
 (19.1 miles away)
305-243-6704
Languages Spoken:
English, Hebrew
See accepted insurances
Accepting New Patients
Offers Telehealth

Gil Yosipovitch is a Dermatologist practicing medicine in Coral Gables, Florida. Dr. Yosipovitch is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Prurigo Nodularis, Atopic Dermatitis, Chronic Spontaneous Urticaria (CSU), and Stasis Dermatitis and Ulcers. Dr. Yosipovitch is currently accepting new patients.

Expertise in
17
conditions
Expertise in
17
conditions
Referral may be required
Before you request
1150 Northwest 14th Street, 
Miami, FL 
 (12.7 miles away)
305-243-6704
Languages Spoken:
English, Bulgarian, German
See accepted insurances
Accepting New Patients
Offers Telehealth

Mariya Miteva is a Dermatologist practicing medicine in Miami, Florida. Dr. Miteva is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Autosomal Recessive Hypotrichosis, Graham-Little-Piccardi-Lassueur Syndrome, Dissecting Cellulitis of the Scalp, and Pili Torti. Dr. Miteva is currently accepting new patients.

Frequently Asked Questions about Dr. Mark S. Nestor

How do I make an appointment with Dr. Mark S. Nestor?

You can book an appointment with Dr. Mark S. Nestor by calling their office at 305-933-6716. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mark S. Nestor a top-rated expert for Keloids?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark S. Nestor is classified as an Distinguished expert for Keloids, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mark S. Nestor specialize in?

While Dr. Mark S. Nestor is a Dermatology, they have specific expertise in Keloids, Actinic Keratosis, and Sunburn. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. Mark S. Nestor participate in research or clinical trials?

Yes. Dr. Mark S. Nestor has published 94 articles and abstracts on conditions like Keloids. You can view a list of Dr. Mark S. Nestor's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mark S. Nestor accept my insurance?

Dr. Mark S. Nestor accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 305-933-6716 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nestor's expertise for a condition
ConditionClose
    View All 15 Advanced Conditions
    View All 58 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile